On December 29, 2022, the Consolidated Appropriations Act of 2023 removed the federal requirement for practitioners to submit a Notice of Intent (NOI), or a waiver application, to prescribe medications like buprenorphine, for the treatment of opioid use disorder (OUD).
Read more